Drug Profile
Research programme: antibacterial therapeutics - Gunsynd
Alternative Names: SYN 0017; SYN 0096; SYN 0854; SYN 101; SYN 102; SYN 1093; SYN 1163Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Syntopix
- Developer Gunsynd
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Acne; Staphylococcal infections
Highest Development Phases
- No development reported Acne; Mouth disorders; Staphylococcal infections
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Acne in United Kingdom (Topical)
- 04 Nov 2017 No recent reports of development identified for preclinical development in Mouth-disorders in United Kingdom (Topical)
- 04 Nov 2017 No recent reports of development identified for preclinical development in Staphylococcal-infections in United Kingdom (Topical)